Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
321 studies found for:    Open Studies | "Shock"
Show Display Options
Rank Status Study
21 Unknown  Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients
Conditions: Sepsis;   Shock, Septic
Interventions: Dietary Supplement: selenium replacement;   Dietary Supplement: Placebo
22 Unknown  Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic Shock
Conditions: Sepsis;   Septic Shock
Intervention:
23 Recruiting Early Use of Norepinephrine in Septic Shock Resuscitation
Conditions: Septic Shock;   Severe Sepsis
Interventions: Drug: Early norepinephrine;   Drug: Placebo
24 Recruiting Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care
Conditions: Septic Shock;   Sepsis
Intervention: Drug: Isotonic crystalloids
25 Recruiting Activated Protein C and Corticosteroids for Human Septic Shock
Condition: Septic Shock
Interventions: Drug: placebos;   Drug: hydrocortisone and fludrocortisone and placebo;   Drug: recombinant human activated protein C and placebos;   Drug: recombinant human activated protein C and hydrocortisone and fludrocortisone
26 Recruiting Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Condition: Cardiogenic Shock
Intervention: Device: HeartMate PHP
27 Recruiting Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
Conditions: Severe Sepsis;   Septic Shock
Intervention:
28 Unknown  Terlipressin Administration in Septic Shock Refractory to Catecholamines
Condition: Septic Shock
Intervention: Drug: terlipressin
29 Recruiting Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)
Conditions: Burns;   Hemofiltration;   Kidney Failure, Acute;   Shock, Septic
Interventions: Device: An FDA approved continuous renal replacement device;   Other: Control Group
30 Unknown  Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress Syndrome
Conditions: Septic Shock;   Acute Respiratory Distress Syndrome
Interventions: Device: PiCCO monitoring (PULSION);   Procedure: central venous catheter
31 Unknown  Effects of Dobutamine on Microcirculation, Regional and Peripheral Perfusion in Septic Shock Patients
Condition: Septic Shock
Interventions: Drug: Dobutamine;   Drug: Placebo
32 Recruiting Echocardiographic Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients
Conditions: Tachycardia;   Septic Shock
Intervention: Drug: esmolol
33 Recruiting Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.
Conditions: Sepsis;   Septic Shock
Interventions: Drug: Human protein C concentrate;   Drug: Activated protein C;   Drug: Placebo comparator
34 Recruiting Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction
Conditions: Acute; Myocardial Infarction, Complications;   Cardiogenic Shock
Intervention: Procedure: Mild hypothermia
35 Recruiting Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
Conditions: Severe Sepsis;   Septic Shock;   Bacteremia
Intervention:
36 Recruiting Non-Invasive Shock: Differentiating Shock in the Emergency Department
Conditions: Shock;   Infection;   Inflammation
Intervention:
37 Unknown  Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
Conditions: Septic Shock;   Thrombocytopenia;   Multiple Organ Failure
Intervention:
38 Recruiting The Effect of Early Cytokine Absorption on the SIRS and Organ Dysfunction in the First 48 Hours of Septic Shock
Conditions: Sepsis;   Septic Shock
Intervention: Device: CytoSorb 300ml device (3804606CE01)
39 Recruiting Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
Conditions: Septic Shock;   Nonchemotherapy Drug-induced Neutropenia;   Neutropenia After Chemotherapy in Oncohematological Patients;   Neutropenia in Patients With Aplastic Anemia
Interventions: Genetic: Mesenchymal stromal cells;   Drug: Standard therapy of septic shock
40 Recruiting Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department
Conditions: Sepsis;   Disease Progression;   Septic Shock;   Fatal Outcome
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years